DUBLIN--(BUSINESS WIRE)--The "India Drug Delivery Devices Market, By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Others), By Patient Care Setting, By Application, By Region, By Region, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.
The Indian Drug Delivery Devices Market was valued at around USD564 million in FY2020 and is expected to grow at a steady CAGR of 8.05% during the forecast period.
The Indian Drug Delivery Devices Market is driven by growing use of drug delivery systems in healthcare facilities. Growing awareness regarding drug metabolism is expected to propel the market growth through FY2026. In addition to this, increasing pervasiveness of chronic infections among the population is further anticipated to bolster the growth of the Indian Drug Delivery Devices Market in a positive way.
With COVID-19 infections rising, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies to prevent the spread of this pandemic and provide optimum care to the infected also widens, which is anticipated to fuel the market growth over the coming years.
The Indian Drug Delivery Devices Market is segmented based on devices, route of administration, patient care setting, application, company, and region. Considering the patient care setting, the market is fragmented into hospitals, diagnostic centres, ambulatory surgery centres, and others.
Among these, the hospitals segment dominated the Indian Drug Delivery Devices Market until FY2020 and is further anticipated to maintain its dominance during the forecast period as well. This high growth can be attributed to the significant number of inpatient and outpatient visits to hospitals and requirement of large volumes of drugs and their respective delivery devices to accommodate to the demand of the large patient pool.
Major players operating in the Indian Drug Delivery Devices Market include Pfizer Limited, Novartis India Limited, India Medtronic Private Limited, GlaxoSmithKline Pharmaceuticals Limited, Cardinal Health India Private Limited, B. Braun Medical India Private Limited, Sun Pharmaceutical Industries Limited., 3M India Limited, Cipla Limited, Bayer Pharmaceuticals India Ltd and others.
The market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements to expand their geographic reach and to increase their customer bases.
Key Target Audience:
- Drug delivery devices manufacturers, suppliers, distributors, and other stakeholders
- Government bodies such as regulating authorities and policy makers.
- Organizations, forums, and alliances related to drug delivery devices.
- Market research and consulting firms
Years considered for this report:
- Historical Years: FY2016-FY2019
- Base Year: FY2020
- Estimated Year: FY2021
- Forecast Period: FY2022-FY2026
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 of India Drug Delivery Devices Market
4. Executive Summary
5. Voice of Customer/Customer Insight
6. India Drug Delivery Devices Market Outlook
7. India Drug Delivery Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device (Syringes, Inhalers, Nebulizer, Transdermal Patches)
7.2.2. By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Others)
7.2.3. By Patient Care Setting (Hospitals, Diagnostic Centres, Ambulatory Surgery Centres, Others)
7.2.4. By Application (Cancer, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Others)
7.2.5. By Region (East, West, North, South)
7.2.6. By Company
7.3. Market Attractiveness Index
8. India Syringe Drug Delivery Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Conventional, Pre-filled, Safety)
8.2.2. By Patient Care Setting
8.2.3. By Application
9. India Inhaler Drug Delivery Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Metered dose inhaler, Dry powder inhaler)
9.2.2. By Patient Care Setting
9.2.3. By Application
10. India Nebulizer Drug Delivery Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Jet, Ultrasonic, Mesh)
10.2.2. By Patient Care Setting
10.2.3. By Application
11. India Transdermal Patch Drug Delivery Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Others
11.2.2. By Patient Care Setting
11.2.3. By Application
12. Market Dynamics
13. Market Trends & Developments
14. Policy and Regulatory Landscape
15. India Economic Profile
16. Competitive Landscape
16.1. Company Profiles
16.1.1. Pfizer Limited
16.1.2. Novartis India Limited
16.1.3. India Medtronic Private Limited
16.1.4. GlaxoSmithKline Pharmaceuticals Limited
16.1.5. Cardinal Health India Private Limited
16.1.6. B. Braun Medical India Private Limited
16.1.7. Sun Pharmaceutical Industries Limited
16.1.8. 3M India Limited
16.1.9. Cipla Limited
16.1.10. Bayer Pharmaceuticals India Ltd.
17. Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/rhiw7d
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900